[Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D007273:Injections, Intramuscular; D009921:Metaproterenol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use; D012138:Respiratory Therapy
D001993:Bronchodilator Agents; D010636:Phenols; D009921:Metaproterenol
Bronchospazmolityczne i "pozaoskrzelowe" działanie preparatu Berotec (Fenoterol, Th 11-65) u chorych na dychawice oskrzelowa lub przewlekłe spastyczne zapalenie oskrzeli